VEGFR2/CD309 antibody (HRP)
Quick Overview for VEGFR2/CD309 antibody (HRP) (ABIN2611323)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Human KDR / VEGFR2
-
Purification
- Caprylic acid and ammonium sulfate precipitation
-
Immunogen
-
Recombinant human Vascular endothelial growth factor receptor 2 protein.
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, IHC, IHC-P, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.03 % Proclin 300, 50 % glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid freeze-thaw cycles.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR / VEGFR2
-
Background
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
Gene ID
- 3791
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-